Back to Search
JOHN SAMPSON, MD
MD
General Practice Physician
NPI: 1376626853IndividualAccepts Medicare
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
4301JS049181(MI)
CMS Specialties
PrimaryHOSPITALIST
Education
HOWARD UNIVERSITY COLLEGE OF MEDICINE
Class of 1981
Research & Publications (20)
Intact and top-down characterization of biomolecules and direct analysis using infrared matrix-assisted laser desorption electrospray ionization coupled to FT-ICR mass spectrometry.
PMID 19185512·J Am Soc Mass Spectrom·2009
7-preclinical
Genotyping and inflated type I error rate in genome-wide association case/control studies.
PMID 19236714·BMC Bioinformatics·2009
8-other
Atmospheric pressure infrared (10.6 microm) laser desorption electrospray ionization (IR-LDESI) coupled to a LTQ Fourier transform ion cyclotron resonance mass spectrometer.
PMID 19504481·Rapid Commun Mass Spectrom·2009
7-preclinical
Construction of a versatile high precision ambient ionization source for direct analysis and imaging.
PMID 18657438·J Am Soc Mass Spectrom·2008
8-other
Development and characterization of an ionization technique for analysis of biological macromolecules: liquid matrix-assisted laser desorption electrospray ionization.
PMID 18656949·Anal Chem·2008
8-other
Direct characterization of intact polypeptides by matrix-assisted laser desorption electrospray ionization quadrupole Fourier transform ion cyclotron resonance mass spectrometry.
PMID 17318926·Rapid Commun Mass Spectrom·2007
8-other
Generation and detection of multiply-charged peptides and proteins by matrix-assisted laser desorption electrospray ionization (MALDESI) Fourier transform ion cyclotron resonance mass spectrometry.
PMID 16952462·J Am Soc Mass Spectrom·2006
8-other
Hydrogen peroxide damages the zinc-binding site of zinc-deficient Cu,Zn superoxide dismutase.
PMID 11469788·Arch Biochem Biophys·2001
7-preclinical
Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.
PMID 19635727·J Med Genet·2010
4-observational
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab.
PMID 19647172·Nucl Med Biol·2009
7-preclinical
A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.
PMID 19519779·J Neurochem·2009
8-other
Paraganglioma of the head and neck: long-term local control with radiotherapy.
PMID 19433962·Am J Clin Oncol·2009
4-observational
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.
PMID 19408307·Int J Cancer·2009
8-other
Efficacy of Solis, NovasilPlus, and MTB-100 to reduce aflatoxin M1 levels in milk of early to mid lactation dairy cows fed aflatoxin B1.
PMID 19620679·J Dairy Sci·2009
7-preclinical
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.
PMID 19591631·Expert Opin Biol Ther·2009
6-review
Toward effective immunotherapy for the treatment of malignant brain tumors.
PMID 19560742·Neurotherapeutics·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1514 4TH ST
JACKSON, MI 49203 - Phone
- (517) 780-0080
Quick Facts
- NPI
- 1376626853
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile